Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | HOWL Werewolf Therapeutics, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $0.96 -2.1% | $14.86 -2.5% |
| StockIQ Score | 57C Moderate Risk: High | 36F Weak Risk: Medium |
| Technical | 70B | 13F |
| Fundamental | 30F | 35F |
| Growth | 54C- | 50C- |
| Fair Value | 55C | 38F |
| News | 100A+ | 50C- |
| Quality | 50C- | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Werewolf Therapeutics (HOWL) outperforms Ascentage Pharma (AAPG) in technical and investor scores, with 72 versus 18 and 57 versus 37, respectively. AAPG has a slightly higher growth score (50 vs. 54) but weaker fundamentals (35 vs. 30) and valuation (38 vs. 55). HOWL’s overall rating is moderate, while AAPG is weak.
